APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

258 hedge funds and large institutions have $4.04B invested in Apellis Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 97 increasing their positions, 71 reducing their positions, and 62 closing their positions.

Holders
258
Holders Change
-4
Holders Change %
-1.53%
% of All Funds
3.44%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
61
Increased
97
Reduced
71
Closed
62
Calls
$104M
Puts
$33.5M
Net Calls
+$70.9M
Net Calls Change
-$15.6M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$307M
2
UBS Group
2
UBS Group
Switzerland
$82.5M
3
National Bank of Canada
3
National Bank of Canada
Quebec, Canada
$44.2M
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$48.5M
5
CWM
5
CIBC World Markets
New York
$41M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$377M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$13.1M
3
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$1.52M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$957K
5
Fiera Capital (Canada)
5
Fiera Capital (Canada)
Quebec, Canada
$0
Name Market Value Shares Shares
Change 		Shares
Change %
IMC Chicago
326
IMC Chicago
Illinois
– – – –
Nomura Asset Management
327
Nomura Asset Management
Japan
– – – –
CFGS
328
Concourse Financial Group Securities
Alabama
– – – –
CAL
329
Capital Advisors Ltd
Ohio
$0 6 +6 New
10 11 12 13
14